Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a combination therapy consisting of Jueyin granules (a traditional Chinese herbal medicine formulation) and narrow-band ultraviolet B (NB-UVB) phototherapy. **Jueyin granules** are composed of seven herbal ingredients including abalone shell, honeysuckle, tree peony bark, dried Rehmannia root, Hedyotis diffusa folium, and turmeric root tuber. They have demonstrated efficacy in reducing symptoms of mild to moderate psoriasis vulgaris by inhibiting keratinocyte proliferation and modulating immune responses. Network pharmacology suggests their effects may be mediated through the vitamin D receptor pathway[2]. **Narrow-band ultraviolet B (NB-UVB)** is a form of phototherapy using UV light at 311–313 nm wavelength. It is an established treatment for inflammatory skin diseases such as psoriasis; it works primarily by suppressing cutaneous cell-mediated immune responses and depleting Langerhans cells and T cells in the epidermis[6][10]. The combination aims to enhance clinical efficacy for moderate-to-severe plaque psoriasis while minimizing side effects compared to monotherapies[1][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on jueyin granules + narrow-band ultraviolet B.